English
Eiko Lifesciences Q2 Results
- BSE: 540204
- NSE: -
- ISIN: INE666Q01016
- Sector: Chemical Manufacturing
BSE
54.10
3.63 (7.19%)
3.63 (7.19%)Volume12.99 K
Updated: Mon 12 Jan, 2026 | 15:26:47
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹11.67 Cr.(43.12%)
- Operating Profit₹1.51 Cr.(486.41%)
- Profit After Tax₹1.08 Cr.(282.23%)
- Operating Margin12.94%(309.73%)
Note: Comparison is on YoY basis
Quarterly - Eiko Lifesciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 10.16 | 9.45 | 7.48% | 7.90 | 28.67% |
| Depreciation/ Amortization | 0.26 | 0.25 | 0.51% | 0.16 | 56.35% |
| Operating Income | 1.51 | 1.26 | 20.10% | 0.26 | 486.41% |
| Net Income | 1.08 | 0.91 | 17.65% | 0.28 | 282.23% |
| Other Operating Expenses Total | 1.05 | 0.77 | 36.04% | 0.47 | 124.47% |
| Net Income Before Taxes | 1.71 | 1.48 | 15.27% | 0.38 | 355.12% |
| Total Revenue | 11.67 | 10.71 | 8.96% | 8.16 | 43.12% |
| Selling/ General/ Admin Expenses Total | 0.14 | 0.13 | 9.39% | 0.07 | 104.77% |
| Diluted Normalized EPS | 0.78 | 0.66 | 18.18% | 0.22 | 254.55% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.